Clinical Trials · NCT03325387
A Study of Multiple Doses of LY3305677 in Healthy Participants
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 56
- Start date
- Oct 2017
- Locations
- 1 site, United Kingdom
- Primary endpoint
- Number of Participants with One or More Serious Adverse Event(s) (SAEs) Considered by the Investigator to be Related to Study Drug Administration